Vantage logo

Point’s path leads to a Spac

The radiopharmaceutical researcher was negotiating a series B funding round when it got an offer from a Spac that it could not refuse.

Vantage logo

Onduo takes its time

The Verily subsidiary has the luxury of patient backers. But hungrier rivals could steal a march.

Vantage logo

Bayer’s gene therapy juggling act

Two arm’s-length acquisitions and two licensing deals have given Bayer a cell and gene therapy unit; now to bring it all together.